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Staphylococcus aureus nasal colonization is an important
risk factor for various S. aureus infections.1 Persistent
carriers and others (formerly: intermittent and noncarriers)
are distinguished based on the risk of infection and anti-
staphylococcal antibody pattern.2by Elsevier Taiwan LLC. This is an open access article under the CC
).
Persistent S. aureus carriage in HIV patients 993S. aureus nasal carriage is higher among human immuno-
deficiency virus (HIV) infected patients than in healthy in-
dividuals.3 However, most investigations conducted in Africa
analyzed a single nasal swab only and risk factors for persis-
tent S. aureus nasal carriage was not considered. This study
was undertaken to provide information on S. aureus persis-
tent nasal carriage amongHIV infected outpatients in Nigeria.
Brief report
This longitudinal study comprised 187 ambulatory HIV
infected patients, asymptomatic for any S. aureus infection
attending the outpatient clinic of Mainland General Hospi-
tal, Lagos, Nigeria, between November 2008 and October
2009. Ethical approval was obtained from the Institutional
Review Board of the Nigeria Institute of Medical Research,
Lagos, Nigeria (IRB/08/065). Written informed consent was
obtained from each participant prior to enrollment. Hos-
pitalized patients were excluded from this study. Socio-
demographic characteristics and medical history [duration
of antiretroviral (ARV) therapy, cotrimoxazole prophylaxis,
CD4þ cell count and stage of HIV infection as defined by the
World Health Organization] were recorded in a standard-
ized questionnaire. Two or three consecutive nasal swabs
were collected randomly from each participant at an in-
terval of 3 months. The swabs were cultured on 5% sheep
blood agar (Oxoid, Basingstoke, Hampshire, UK) and
mannitol salt agar (Oxoid) at 37C overnight. Presumptive
colonies were identified as S. aureus based on positive re-
sults for catalase, tube coagulase, and latex agglutination
tests (Diamondial, Sees, France) and confirmed by poly-
merase chain reaction detection of the coagulase gene.4
Susceptibility testing was performed by the KirbyeBauer
agar disc diffusion method using the following antibiotics:
penicillin (10 units), methicillin (5 mg), chloramphenicol
(30 mg), tetracycline (30 mg), erythromycin (15 mg), cipro-
floxacin (5 mg), and cotrimoxazole (1.25/23.75 mg), and was
evaluated according to Clinical Laboratory Standard Insti-
tute breakpoints. Persistent carriage was defined asTable 1 Risk factors for persistent Staphylococcus aureus nasal
2008e2009
Predictors Persistent
carrier
(n Z 51)
Others (in
and non-c
(n Z 136
Sex, female n (%) 40 (78.4) 110 (80.9
Age (y) Mean  SD 39.9  9.9 41.0  9.
CD4þ cell countb
(cells/mL)
Mean  SD 173.7  106.8 484.4  2
HIV stage I Number (%) 40 (78.4) 120 (88.2
HIV stage II/III Number (%) 11 (21.6) 16 (11.8)
Duration of current
ARV (mo)
Median (range) 6 (0-60) 12 (0-60)
Duration of current
cotrimoxazole
prophylaxis (mo)
median (range) 7 (0-96) 14 (0-60)
ARV Z antiretroviral drug; CI Z confidence interval; OR Z odds rati
a Adjusted for age, sex.
b CD4þ counts were not available for two persistent carriers and siisolation of S. aureus in at least two consecutive nasal
swabs. Resistance to methicillin was confirmed by detec-
tion of mecA. Detection of the PantoneValentine leukoci-
din gene (lukF-PV, lukS-PV) and spa typing (Staph Type
2.1.1; Ridom GmbH, Mu¨nster, Germany) was done as pub-
lished.5 Clusters of related spa types (spa-clonal complex,
spa-CC) were identified using the based upon repeat
pattern algorithm with preset parameters as published.6
Multilocus sequence typing was carried out on the four
most prevalent spa types.7 Statistical analyses were per-
formed using R and the package epicalc. A logistic regres-
sion analysis was used to compute the probability of
persistent S. aureus colonization (outcome) under the
studied set of risk factors (exposures) in a persistent carrier
vs. others comparison. All risk factors with a significance
level of p < 0.1 in the univariate analysis were adjusted for
age and sex in a multivariate analysis. Age and sex are
known risk factors for persistent carriage.8 Association
between categorical variables was assessed using Chi-
square test and Fisher’s exact test where appropriate and
odds ratios (OR) and the 95% confidence interval (95% CI)
was calculated. The significance level was 5%.
Women were predominant in the whole study population
(80.2%, n Z 150), and in persistent carriers only (n Z 40,
78.4%). Out of the 187 patients included in this study, a
total of 500 nasal swabs were collected. Of these, 176 (35%)
patients were positive for S. aureus. Fifty-one (27%) HIV
patients were defined as persistent carriers. Fifty-three
(28%) patients were intermittent carriers and 83 (44%)
were noncarriers. Low CD4þ cell counts were a strong risk
factor of persistent carriage (Table 1). The proportion of
persistent carriage was increased compared to nonpersis-
tent colonization in patients with advanced HIV infection
(WHO II/III, 21.6% vs. 11.8%, OR Z 2. 1, 95% CI: 0.8e5.2,
p Z 0. 09, Table 1) but we failed to detect statistical sig-
nificance. The association of persistent carriage with low
CD4þ cell counts and advanced HIV stage remained stable
after adjusting for age and sex (Table 1). There was a lower
proportion of persistent carriers in participants, who werecarriage in human immunodeficiency virus patients, Nigeria,
termittent
arrier)
)
Crude OR
(95%b CI)
p Adjusted ORa
(95%b CI)
pa
) 0.9 (0.4e2.1) 0.7
1 1.0 (1.0e1.0) 0.5
13.2 1.0 (1.0e1.0) <0.001 1.0 (1.0e1.0) <0.001
) 0.5 (0.2e1.3) 0.09 0.5 (0.2e1.1) 0.1
2.1 (0.8e5.2) 0.09 2.1 (0.9e4.8) 0.1
1.0 (1.0e1.0) 0.6
1.0 (1.0e1.0) 0.3
o; SD Z standard deviation.
x others.
994 A.O. Olalekan et al.on ARV drugs for >1 year compared to participants who
were on ARV for <1 year (13.7% vs. 25.7%, OR Z 0. 5, 95%
CI: 0.2e1.2, p Z 0. 08). The antimicrobial susceptibility
tests of nonduplicates isolates showed high resistance rates
to cotrimoxazole (92%, n Z 112), chloramphenicol (53%,
n Z 65), methicillin (16%, n Z 20), ciprofloxacin (25%,
n Z 31), erythromycin (65%, n Z 79), tetracycline (71%,
nZ 86), and penicillin (100%, nZ 122). ThemecA gene was
detected in all phenotypically methicillin-resistant isolates.
Notably, the mean number of CD4þ cells was significantly
lower in methicillin-resistant S. aureus (MRSA) carriers vs.
others, comprising methicillin-susceptible S. aureus car-
riers and noncarriers (293.7/mL vs. 413.4/mL, p Z 0.03).
The PVL gene was detected in 71 (40%) isolates. Of the 51
(100%) persistent carriers, 33 (64%) carried S. aureus with
the same spa types, and 17 (33%) harbored isolates
belonging to completely different spa types. The spa types
of isolates from persistent carriers belonged to the following
spa-CCs: spa-CC 064 [spa types (number of isolates in
brackets): t008 (1), t064 (12), t304 (1), t967 (1), t1476 (1),
t2658 (1), t6863 (2), t7808 (1)]; spa-CC 3772 [t3772 (12),
t4683 (1), t6206 (1), t7802 (1)]; spa-CC 084 [t084 (4), t085
(1), t774 (1), t7806 (1)]; spa-CC 311 [t311 (3), t1400 (1),
t7801 (1)]; spa-CC1156/7805 [t1156 (1), t7805 (1)]; spa-
CC7796/7857 [t7796 (1)]; spa-CC7810/7856 [t7856 (1)];
spa-CC786 [t786 (1), t1603 (1)]; and spa-CC355/1172 [t355
(3)]. Isolates belonging to spa types t2304 (2), t2554 (3),
t4976 (1), and t5058 (1) were excluded from this analysis
(repeats <5). Also spa type t159 (1), t318 (1), t1458 (2), and
t7813 (1) were singletons, and isolate from one persistent
carrier was not typeable. The spa types from intermittent
carrier clustered into spa-CC 064 [t064 (3), t197 (1), t701 (1),
t1476 (1), t1774 (1)]; spa-CC 3772 [t3662 (1), t3772 (9), t4678
(2), t4683(1), t7807 (1), t7817 (2)]; spa-CC 084 [t084 (4)];
spa-CC 311 [t311 (3)]; spa-CC7796/7857 [t7857 (1)]; spa-
CC7810/7856 [t7810 (1)]; spa-CC786 [t786 (2), t1603 (1),
t4385 (1)]; and spa-CC355/1172 [t1172 (1)]. Isolates
belonging to spa types t2304 (3) and t4976 were excluded
from analysis (repeats <5), while spa type t934, t939 and
t7804 were singleton, and nine isolates were not typeable.
The following spa types and corresponding STs were most
frequently found: t3772/ST25 (nZ 38), t084/ST15 (nZ 14),
t064/ST8 (nZ 28), and t311/ST5 (nZ 7). Interestingly, spa-
CC 064 was clearly associated with persistent carriage
(OR Z 2.7, 95% CI Z 1.0e8.2, p Z 0.04).Discussion
This is the first study from Nigeria reporting the proportion
of persistent S. aureus nasal carriage in HIV-patients and
the associated risk factors for persistent S. aureus nasal
carriage. The reason for the higher number of female pa-
tients visiting the HIV outpatient clinic might point toward a
higher health awareness or burden of HIV infection in young
women which is mirrored by a 3e7-fold higher prevalence
of HIV infection among women compared to adolescent
men in sub-Saharan Africa.9 The persistent carriage of 27%
in this study reflects the proportion of persistent carriers in
Dutch HIV patients (29.6%) but is higher compared to
healthy Dutch volunteers (24%).10 We found that a low
CD4þ cell count is significantly associated with persistentcarriage (Table 1). It is known that the impairment of the
immunosystem is a risk factor for S. aureus colonization in
general and persistent colonization in particular. While the
exact mechanism of S. aureus clearance remains largely
unknown in humans, mouse models suggest that decoloni-
zation of S. aureus is T-cell dependent.11
Our results indicate that S. aureus of HIV-infected pa-
tients display a high rate of antimicrobial resistance; most
of the isolates were resistant to three or more groups of
antimicrobial agents. The reason is that antimicrobial
resistance is common in Nigeria as there are no guidelines
and restricted access to drugs.12 The higher resistance rate
against cotrimoxazole might be associated with the
frequent use of this compound for Pneumocystis jirovecii
prophylaxis, but no association between cotrimoxazole
prophylaxis and cotrimoxazole resistance in S. aureus iso-
lates was detected (OR Z infinity, 95% CI: 0.23einfinity,
p Z 0.6).
The proportion of PVL positive isolates in this study was
high, which is similar to other reports from Africa.5 In
addition, not all S. aureus from persistent carriers showed
the same genotype, indicating the diversity of strains
colonizing the same patients. This information is important
in planning intervention strategy necessary to prevent
serious S. aureus infection in this population.
Two limitations of this study need to be addressed. First,
we did not collect all relevant factors associated with
colonization of S. aureus. Hence, caution should be applied
in generalization of our findings. Second, we did not apply
the cefoxitin screen test as recommended by Clinical Lab-
oratory Standard Institute to screen for MRSA. As the
methicillin/oxacillin disks are less sensitive in the detection
of methicillin resistance, we might underestimate the
prevalence of MRSA in our study. However, the MRSA
phenotype is reliable, as all isolates were mecA positive.
In conclusion, the proportion of persistent carriers
seems to increase with advanced immunosuppression, but
can be reduced by long-term use of ARV therapy.Conflicts of interest
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